Obicetrapib
Intermediates
- Obicetrapib is a new investigational cholesterol-lowering drug that works by inhibiting CETP, helping to reduce LDL and increase HDL levels. Reference standards of Obicetrapib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => tert-Butyl 4-((2-chloropyrimidin-5-yl)oxy)butanoate
[catalogue_number] => PA 15 1341000
[category_ids] => ,75,70,78,82,
[chemical_name] =>
[weight] => 272.73
[form] => C12H17ClN2O3
[cas] => 945771-55-1
[pslug] => 945771-55-1-tert-butyl-4-2-chloropyrimidin-5-yl-oxy-butanoate-pa151341000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
tert-Butyl 4-((2-chloropyrimidin-5-yl)oxy)butanoate
Catalogue No.:PA 15 1341000
Molecular Formula : C12H17ClN2O3
Molecular Weight : 272.73